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Running title 
 
RBL cells as models for in vitro studies 
 
 
 
Summary  
 
 
 
Since their establishment in 1981, RBL-2H3 cells have been widely used as a mast cell model. 
Their ability to be easily grown in culture in large amounts, their responsiveness to FcεRI 
mediated triggers and the fact that they can be genetically manipulated, have provided 
advantages over primary mast cells, in particular for molecular studies relying on genetic 
screening. Furthermore, the ability to generate clones that stably express proteins of interest, for 
example a human receptor, have marked the RBL cells as an attractive mast cell model for drug 
screening. Indeed, three RBL reporter cell lines (RS-ATL8, NFAT-DsRed, and NPY-mRFP) 
have been generated providing useful models for drug and allergen screening.  
 
Similarly, RBL cells stably expressing the human MrgprX2 receptor provide a unique 
paradigm for analyzing ligand interactions and signaling pathways of the unique human 
receptor. Finally, transient co-transfections of RBL cells allow functional genomic analyses of 
mast cell secretion by combining library screening with simultaneous expression of a reporter 
for exocytosis. RBL cells thus comprise powerful tools for the study of intracellular membrane 
trafficking and exocytosis and the detection of allergens, vaccine safety studies and diagnosis 
of allergic sensitization. Their recent uses as an investigative tool are reviewed here. 
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Animal model systems are an essential factor in disease research. An animal model that 
recapitulates properly the pathophysiological aspects of a human disease can facilitate the 
development of diagnostic means as well as the development of therapeutics, thus playing an 
important role in preclinical studies. However, to define the molecular basis of a disease and 
define the cellular pathways involved, cellular models are required to allow the study of the 
specific contributions of cells that are linked with the development of a disease. Such models 
provide invaluable tools for the identification of drug targets and for screening for genetic, 
environmental or pharmacological risk factors of the disease. Finally, cellular models also 
provide useful tools for testing the efficacy of potential drugs. In line with this premise, mast 
cell (MC) models have been developed for studying the molecular basis of allergy, a family of 
diseases, which share their onset upon the release of inflammatory mediators from activated 
MCs. The latter, including vasoactive amines such as histamine, proteases such as tryptase, 
proteoglycans such as heparin, lysosomal enzymes such as -hexosaminidase and some 
cytokines, are pre-stored in cytoplasmic secretory granules (SGs) and released by exocytosis 
following MC activation by external triggers.1-5 This initial event of exocytosis is followed by 
the de novo synthesis and release of a large array of biologically potent substances, including 
metabolites of arachidonic acid, multiple cytokines and chemokines.6-9 Collectively, these 
mediators thus initiate early and late inflammatory responses. The best-characterized mode of 
MC activation is the immunological pathway caused by allergen/antigen (Ag)-induced 
crosslinking of Immunoglobulin E (IgE) antibodies that are bound to their high affinity IgE 
receptor, FcεRI that is expressed on the MC surface.10-12 However, MCs can respond to many 
different stimuli (e.g., cytokines, bacterial products, neuropeptides, venom components, etc.) 
and participate in a wide variety of IgE-independent physiological and pathological processes.13, 
14 
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MCs arise from committed progenitors (CD34+, c-kit positive cells) in the bone marrow, which 
traverses the vascular space and enter the tissues.15-17 The cells then complete their 
differentiation and maturation process in situ. Hence, MCs are present in most tissues in the 
vicinity of blood vessels. However, they are especially prominent at the interface between the 
outside environment and the internal milieu, in tissues such as the skin and the respiratory and 
digestive tracts.18  
That MCs are tissue resident cells and that even in the tissue their numbers are limited 
raises difficulties in obtaining large number of cells that are normally needed for studies aimed 
at elucidating mechanisms underlying MC processes such as MC secretion or stimulus-
secretion coupling mechanisms. There are also difficulties in maintaining primary MCs in 
culture and almost impossible to manipulate them genetically, which is often required for 
identification of the machineries involved in MC function. Model systems are therefore 
indispensable for molecular research of MCs in vitro. Towards this end, a number of models 
have been developed. The latter are based either on in vitro culturing of stem cells, for example 
culturing of mouse bone marrow derived MCs (BMMCs),19 or culturing of human cord blood 
derived MCs20 or in vitro maturation of MCs from peripheral blood.21 In addition several cell 
lines have been developed from human and rodent sources including the human HMC-1, LAD-
2 and LUVA cell lines,22-24 the murine MC/9 cell line25 and the rat basophilic leukemia cell line, 
RBL-2H3, herein referred to as RBL.26 The latter is the focus of this review, where we will 
summarize the limitations of this model vis-à-vis their value as MC model. We will also 
describe the newer RBL cell-based models and their important applications. 
 
1. The creation of the RBL-2H3 cell line 
RBL cells were generated by injecting rats with the chemical carcinogen -chlorethylamine.27 
Tumors generated by the injected rats were subsequently adapted to culture.28 Binding assays 
revealed that the cells, termed RBL-1, bound specifically IgE.28, 29 Nevertheless, RBL-1 failed 
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to release histamine in response to either an IgE/antigen trigger or chemical stimulation by a 
Ca2+ ionophore.30 However, subsequent cloning of the cells gave rise to the isolation of a 
responsive subline, that degranulated in response to an IgE trigger, hence the RBL-2H3 
subline.26 Since their establishment in 1981, RBL cells underwent two phases. Shortly after 
their formation, RBL cells were considered a reliable model, which was extensively used to 
study the IgE receptor. However, their credibility and suitability was later questioned.31, 32 In 
this review, we will revisit the question of reliability of the RBL cells as an adequate model for 
MC research.  
 
2. The role of RBL cells in IgE receptor research 
The availability of the RBL cells that could be grown in culture in large quantities provided a 
unique opportunity to study the properties of the FcRI. The binding characteristics of IgE, i.e. 
dependence on temperature, sensitivity to metabolic inhibitors33 as well as quantitative aspects 
of the binding reaction34 could be analyzed by the use of this cell line. Moreover, the receptor 
could be solubilized,35, 36 an achievement that has eventually paved the road for the cloning of 
the receptor,37-40 receptor crystallization41 and generation of transgenic mice.42 RBL cells also 
provided an excellent paradigm to decipher the signaling cascades of the FcRI.43 Signaling 
pathways elicited by the receptor were delineated and adaptors involved in the stimulus 
secretion coupling mechanisms in MCs were identified.12, 44-46 Finally, RBL cells were used to 
analyze the fate of the receptor,47-49 eventually leading to the discovery of the role played by 
ubiquitination and E3 ligases in receptor regulation.50-52  
 
3. RBL cells: MCs or basophils? 
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Whether the phenotype of RBL cells is closer to basophils or to MCs is an old dispute.31, 32, 53 
Here, we will briefly attempt to show that the debate is not only unresolved, but perhaps 
unresolvable — but: does it really need to be resolved?  
From a morphological point of view, RBL cells grow firmly attached to the culture 
vessels, forming monolayers and displaying an elongated morphology which does not fully 
resemble MCs but even less so that of basophils, and is much more reminiscent of fibroblast 
morphology. 54 In contrast, transmission electron microscopy of RBL-2H3 cells 55, 56 suggests a 
heterogeneous distribution of granule sizes and densities which is closer to what is seen in 
peripheral blood basophils than the dense and more homogeneously sized granules of MCs.57   
At the molecular level, there are clear discrepancies from (human) basophils, such as the lack 
of detectable expression of N-formyl peptide (FPR) or complement (C5aR) receptors.58 In fact, 
several studies have introduced fMLP receptors into RBL-2H3 by transfection.58, 59 
Additional differences between RBL and basophils have been described regarding the 
effects of Toll-like receptor (TLR) agonists, e.g. by the TLR-4 ligand Lipopolysaccharide 
(LPS). While both peripheral blood basophils60 and RBL cells61 appear to express TLR-4, RBL 
cells are not activated by LPS, possibly because they lack the essential co-receptor CD14.61 
However, LPS also does not directly activate peripheral blood basophils,62 despite the apparent 
presence of CD14,63 while it appears to synergize with IgE-dependent stimuli.62 We have not 
found any information about the presence of TLR-2 on RBL cells. Therefore, it appears that 
several receptors linked to RBL activation are differentially expressed between RBL cells and 
basophils.  
But what about the highly studied markers CD63 and CD203c on human basophils? Are 
these shared with RBL cells? Human basophil activation via the high affinity IgE receptor can 
be monitored by measuring changes in the surface expression of activation markers, such as 
CD63 and CD203c. CD63 is a glycoprotein member of the transmembrane 4 superfamily 
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(TM4SF) and is also known as lysosome associated membrane protein-3 (LAMP-3). Its 
expression is not unique to human basophils, but due to its strong (up to 100-fold) upregulation 
during anaphylactic degranulation,64 it is eminently useful for measurement of basophil 
activation. CD203c is a type II transmembrane glycoprotein belonging to the family of ecto-
nucleotide pyrophosphatase/phosphodiesterase (E-NPP3) enzymes, and is a specific marker for 
basophils in peripheral blood,65 CD63 and/or CD203c, usually in combination with other 
surface antigens needed to unambiguously identify basophils in peripheral blood samples by 
flow cytometry, form the basis of most commercial or experimental basophil activation tests.66 
Typically, resting basophils have very low levels of surface CD63, while CD203c levels are 
intermediate. CD63 is located in the granular membrane and inserted into the cytoplasmic 
membrane during degranulation, an event that involves fusion of granular and plasma 
membrane.67, 68 In contrast, CD203c appears to be recruited from other pre-existing 
intracellular pools, leading to its rapid (3-5-fold) upregulation on the cell surface post-
activation.69 Can these two surface activation markers help resolve the MC vs basophil dispute? 
Unfortunately, there is little knowledge regarding the expression of CD203c on the RBL 
surface, perhaps due to the lack of suitable specific antibodies. We and others have found 
CD63 levels on RBL cells to be elevated also on resting cells; Kitani et al.70 describe 1.1 x 105 
CD63 molecules per cell: a striking difference to the barely measurable levels of CD63 
expression on resting human basophils. 
Another molecule expressed on the surface of RBL cells, is c-kit, the proto-oncogene 
tyrosine kinase acting as receptor for stem cell factor (scf).71 In contrast, basophils are c-kit 
negative. Vice versa, the receptor for IL-3 (CD123), which is highly expressed on basophils,72 
has not been described on RBL-2H3. Considering the central roles of IL-3 and scf for growth 
and development of basophils and MCs, respectively, this dichotomy clearly appears to put 
RBL cells in closer proximity to MCs rather than basophils. However, bearing in mind the 
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highly aberrant karyotype of RBL-2H3 cells, whether or not they can be considered a suitable 
model for MCs, depends on the context of what is studied. 
 
4. RBL cells as reliable model for studies on exocytosis 
Numerous studies indicate similar mechanisms of exocytosis of BMMCs and RBL cells thus 
marking the RBL cells as an appropriate model for studies on MC exocytosis. In support of this 
notion are the reports that demonstrated the involvement of same SNARE proteins in mediating 
the fusion events that lead to degranulation in either cell type. Immunohistochemistry studies 
have further supported these studies by demonstrating similar cellular locations of the SNARE 
proteins in primary MCs and RBL cells, whereby SNAP23 and syntaxin 4 localize to the 
plasma membrane and syntaxin 3 and VAMP-2, −3, −7 and −8 primarily localize to the SGs 
(reviewed in73). Furthermore, similar protein interactions between SNARE proteins were noted 
in the primary MCs and the RBL cells, demonstrating protein complexes consisting of SNAP-
23, Syntaxin 4 and VAMP-2, VAMP-8, VAMP-7 and VAMP-3 (reviewed in73). Functional 
assays further confirmed this notion by comparing MCs derived from knockout mice and 
knockdown RBL cells. For example, BMMCs derived from VAMP8-deficient mice exhibit 
reduced degranulation74 and similarly, VAMP8 was identified as major SNARE in the release 
of  hexosaminidase from RBL cells.75  
Not only the fusion machineries used by BMMCs and RBL are similar, but this is also 
true for the accessory proteins that regulate SNARE function, SG motility or SG size. The latter 
include the Sec/Munc (SM) protein Munc18-2 that regulates SNARE function and SG 
motility,76 the Rab GTPases, Rab 1277 and Rab2778 that respectively regulate retro and 
anterograde transport of the SG and Rab5 that regulates SG fusion and size.79 
MC exocytosis is associated with remarkable cytoskeletal changes. To gain insight into 
the factors that govern these cytoskeletal changes, a pharmacological screen of Rho family 
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inhibitors was recently conducted testing the impact of inhibitors of members of the Rho family 
of GTPases on MC secretion.80 The results of this study conducted on both FcεRI-activated 
BMMCs and RBL cells revealed similar drug sensitivities, therefore implicating similar actin 
signaling linked with BMMC or RBL stimulated exocytosis.80 These results are consistent with 
previous studies of direct measurements of actin rearrangements that occur during exocytosis of 
BMMC or RBL that documented similar actin remodeling.81, 82 
 
5. The new generation of RBL cell based models 
5.1. Humanized RBL cells as model system for screening allergens/anti allergic drugs 
5.1.a. RBL-SX-38; RBL-48; RBL30/25: the human FcRI expressing RBL cells: 
The expression of the high affinity IgE receptor FcRI on RBL cells suggested that this cell line 
could be used for detection of allergen-specific IgE and allergens. However, while the human 
IgE receptor is able to bind both rodent and human IgE,83 the rodent receptor does not bind 
human IgE.84 Thus, for use with human samples, the RBL cells first had to be transfected with 
the human FcεRI receptor.85 The suitability of RBL cells for screening purposes became clear 
in the early 90s when RBL cells were transfected with the α chain of the human FcεRI and 
shown to maintain functionality. Stable transfection of RBL cells with the human FcεRI α 
chain yielded a cell surface expressed receptor that mediated antigen-induced signaling and 
mediator release.85-88 Such humanized RBL cells were then used to test the capacity of purified 
peanut allergens to induce degranulation89-91 or food allergens.92 Since then, the RBL cells have 
also been transfected to express equine93 and canine94 high affinity IgE receptor α chains, 
extending their use to other mammalian species. 
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5.1.b. MrgprX2-expressing RBL cells as model for basic secretagogue-induced signaling 
and secretion 
Alongside their well characterized Ag/IgE stimulated and FcRI-mediated response, MCs can 
also be activated independently of IgE by numerous ligands, including ligands of Toll like 
receptors95 and adenosine.96 Intriguingly, a subset of MCs, connective tissue type MCs in 
rodents or MCs that contain both tryptase and chymase in their SGs (MCTC) in humans, 
selectively respond to a family of cationic stimuli and polybasic compounds. The latter 
collectively known as the basic secretagogues of MCs include neuropeptides such as substance 
P, toxins such as the wasp toxin mastoparan and numerous positively charged chemicals such 
as the synthetic compound 48/80 (c48/80) and many drugs.13 Basic secretagogues are enigmatic 
because they share no sequence homology, apart from their common positive charge, and yet 
they seem to share a common mechanism of action reflected in the requirement for a high, 
micromolar range concentration to elicit their responses, their relatively rapid secretory 
response and sensitivity to pertussis toxin (PTX).97 Studies by others and us addressing the 
mode of action of basic secretagogues in rat peritoneal MCs, a model for connective tissue type 
MCs in rodents, have suggested that these secretagogues activate MCs in a receptor-
independent manner, by directly activating Gi proteins. We have then identified Gi3 as a 
crucial mediator of basic secretagogue-induced MC degranulation.98 Interestingly, basic 
secretagogues stimulated secretion and basic secretagogues stimulated signaling, reflected in 
the activation of protein tyrosine kinases including the syk kinase and phosphorylation of the 
ERK1/2 MAP kinases99, 100 displayed distinct dose response relationships suggesting the 
existence of two cellular targets of basic secretagogues. In consistence with such notion, 
recently, the Kulka Lab has shown that MCs’ differential response to basic secretagogues is 
dependent upon the expression of the Mrgpr receptor.14 This extremely important observation 
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thus provided new mechanistic insights into the mode of action of basic secretagogues and their 
differential activity. 
MAS-related G protein coupled receptors (Mrgprs) or sensory neuron-specific receptors 
(SNSRs) comprise a multigene family of G protein coupled receptors (GPCRs) that have 
expanded in a species-dependent manner through evolution (reviewed in 101). Interestingly, 
most amino acid alterations occurred in the extracellular domains of Mrgprs, implying that 
Mrgpr evolution was adaptive affecting their capacity to recognize diverse ligands according to 
each species need (reviewed in 102). Humans (and other primates) express four MrgprX genes: 
MrgprX1-X4, whereas rodents have one gene each of MrgprA, MrgprC, and MrgprD and 10 
genes of MrgprB (reviewed in 102). Though the receptors are still considered "orphan", many 
ligands, including amino acids and peptides, have been shown to bind to this receptor class 
(reviewed in 103). Mrgprs are predominantly expressed in dorsal root ganglia (DRG) and are 
therefore considered sensory neuron-specific receptors (SNSRs), whose function is linked with 
nociception and pain.104 However, apart from DRG, the second major site of Mrgprs expression 
is in MCs. Human MCs, including cord blood-derived MCs (CBMCs), skin MCs and the 
LAD2 MC line, but not lung MCs, express considerable levels of MRGPRX2 and small 
amounts of MRGPRX1 (reviewed in 102, 103). Strikingly, human MCs contain more MRGPRX2 
than FcRI,105 thus indicating the importance of this receptor in MC function. Several lines of 
complementary evidence implicate Mrgprs as the ‘basic secretagogue receptors’ in MCs. First, 
screening of peptide and chemical libraries using a reporter gene assay demonstrated that a 
number of known basic secretagogues of MCs could increase reporter gene expression in 
HEK293 cells transfected to express MRGPRX2;106 second, endogenous expression of Mrgprs 
in MCs correlates with their responsiveness to basic secretagogues;106 third, studies by the Ali 
Lab have demonstrated that RBL cells, that do not normally respond to basic secretagogues, 
acquired such responsiveness upon stable transfection with MRGPRX2;107 finally, Kulka and 
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Dong demonstrated that basic secretagogue-induced responses are inhibited in an Mrgprb2-
receptor deficient mouse model, thus identifying Mrgprb2 as the basic secretagogue receptor in 
mouse MCs.108 Collectively, these findings strongly implicate Mrgprs as mediators of 
neurogenic inflammation, that is initiated by MC activation by neuropeptides such as substance 
P (SP), vasoactive intestinal peptide (VIP) and calcitonin gene related peptide (CGRP) that 
were shown to activate MCs independently of the canonical receptors by a mechanism shared 
with other basic secretagogues (reviewed in 109, 110). Furthermore, in view of the fact that many 
FDA approved drugs act as basic secretagogues capable of activating MCs, MRGPRX2 is 
likely to mediate pseudoallergic reactions caused by such drugs (reviewed in 109, 110). However, 
the species variability of these receptors and the potential variations in their ligand recognition 
raise important concerns regarding the applicability of experiments in animal models for 
predicting the pseudoallergenic potential of drugs in humans 14 (reviewed in 109).  In this regard, 
the model developed by the Ali group of RBL cells that are stably transfected with the human 
MRGPRX2, offers excellent opportunities to explore the role of the human receptor in MCs, 
while overcoming the drawbacks of using human MCs that express endogenously the receptor. 
Indeed, unlike CBMCs whose source is limiting or the LAD2 human MC line, whose doubling 
time is one week, RBL cells grow fast and can be easily grown in 96- or 348-well plates that 
are suitable for high throughput screening. Moreover, the selective responsiveness of 
MRGPRX2 expressing, but not native RBL cells to basic secretagogues allows discrimination 
of drug toxicity, reflected as toxic release of mediators from native RBL cells, from genuine 
MRGPRX2 mediated release, as well as discrimination between responses mediated by 
canonical receptors of a subset of basic secretagogues, for example, responses to SP that are 
mediated by the canonical Neurokinin 1 receptor (NK-1R) receptor that is endogenously 
expressed in RBL cells and MRGPRX2-mediated responses. Indeed, by using this system of 
stably transfected RBL cells, the Ali group was able to demonstrate that PMX-53, an 
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antagonist of CD88, the receptor of C5a, displays dual activities. Hence, while PMX-53 
inhibits CD88, it induced degranulation of MRGPRX2-expressing RBL cells that do not 
express CD88.102 Similarly, the human  defensins, hBD2, hBD3, and CST, small cationic 
antimicrobial peptides that play an important role in host defense against pathogens, induced 
substantial degranulation of MRGPRX2 expressing RBL cells demonstrating the capacity of 
these antimicrobial peptides to bind to and activate the human MRGPRX2.111 Therefore, 
collectively, these results mark MRGPRX2 expressing RBL cells as a useful model for future 
screening and evaluation of allergic potential of polycationic molecules. 
 
5.2. Reporter expressing RBL cells 
5.2.1 RS-ATL8: The luciferase expressing humanized RBL cell line 
A further improvement of humanized RBL cells consisted in introducing a reporter gene 
(firefly luciferase), allowing easy and highly sensitive measurement of cellular activation via 
the IgE receptor. The first humanized reporter cell line was created by Nakamura and 
colleagues;112 the system is a NFAT-firefly luciferase reporter, which, rather than reporting 
degranulation, is linked with the branch of IgE-dependent signal transduction resulting in de 
novo cytokine synthesis. Nuclear Factor of Activated T-cells (NFAT) proteins belong to a five-
membered family of transcription factors, whose subcellular localization is ultimately 
determined by intracellular calcium concentrations and the existence of a Nuclear Localization 
Signal (NLS) located in the N-terminal third of the molecule.113 In a resting state, this NLS is 
masked by multiple phosphorylation as the result of serine/threonine kinases, such as casein 
kinase and glycogen synthase kinase 3,114 which phosphorylate serine residues in serine-rich 
regions (SRRs) and three SPXX-repeat motifs (SPs) found in NFAT. Stimulation of the RBL 
cells via the high affinity IgE receptor results in sustained calcium influx, leading to activation 
of Calcineurin, a phosphatase that dephosphorylates NFAT, leading to unmasking of the NLS 
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and subsequent nuclear translocation.115 In the nucleus, NFAT binds to specific promoter sites 
and initiates gene transcription, and in the case of the RS-ATL8 cells, transcription of the 
luciferase reporter gene. Thus with these reporter cells, activation can be measured, peaking 3-4 
hours after activation, by lysing the cells and measuring luciferase activity with appropriate 
substrates and a luminescence detector.  
The RS-ATL8 is a very sensitive reporter system, able to detect an allergen concentration 
of 15 fg/ml, using a threshold for positivity defined as the double of the background (without 
serum).112 The high sensitivity also allows to get around issues of serum toxicity, partially due 
to activated complement; such issues are avoided when diluting the sera to be tested 1:100.112 
Such dilution would result in likely failure to detect activation if measuring beta-
hexosaminidase, the traditional way of measuring RBL cell degranulation, using a fluorimetric 
assay first described by Leaback and Walker in 1961.116 When using RS-ATL8 cells, it is not 
necessary to use additional chemicals such as deuterated water117 or N-
ethylcarboxamidoadenosine (NECA),118 sometimes used for enhancement of degranulation. 
This sensitive RS-ATL8 assay has since been used for detection of food or other 
allergens and is amenable to high throughput format.119,120 It has also been suggested for 
assessment of allergenicity of anti-schistosome vaccine candidates121 and for other purposes, as 
described recently by us.122 
 
5.2.2. Humanized NFAT-DsRed expressing RBL cells 
While the RS-ATL8 is exquisitely sensitive, it has two main drawbacks. Firstly, its routine use 
is relatively expensive due to the need for luciferase substrates. This factor can be reduced by 
transferring the assay from e.g. 96-well to 384-well plates, without major loss of sensitivity.119 
More importantly, the RS-ATL8 is not suitable for assessment of activation on allergen arrays, 
as luciferase detection requires cell lysis, thus disconnects the fluorescent signal from the 
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location of the allergen spot causing activation on an array slide. To overcome this limitation, 
we developed a fluorescent reporter system, which similarly to the RS-ATL8, reports IgE-
dependent NFAT nuclear translocation by inducing DsRed protein expression (NFAT-DsRed 
RBL).123, 124 
 
5.2.3. Humanized NPY-mRFP expressing RBL cells  
The NFAT reporter cell lines RS-ATL8 and NFAT-DsRed RBL sensitively report 
IgE/FcεRI-mediated cell activation. However, these reporters protein do not directly mirror 
the degranulation event. Thus, the aforementioned reporter lines are not suitable for studies 
addressing degranulation. A new reporter cell line had to be created for such experiments, 
using the subcellular compartment targeting properties of Neuropeptide Y (NPY). NPY is a 
36 amino acid peptide, discovered in 1982 by Tatemoto et al..125 which localizes to 
electron-dense secretory granules. Lang et al. first showed that expression of NPY fused 
with a fluorescent protein could be used to label granules in a neuronal cell line, PC12, 
using a NPY-GFP fusion.126 This system has also been used for in vivo imaging in mice by 
Ramamoorthy et al.. 127 In the Lang et al. study, a specific variant of GFP had to be used, as 
earlier variants of GFP were not stable in secretory granules, due to the acidic environment 
and dense protein matrix. Degranulation of PC12 cells could be conveniently measured by 
quantifying fluorescence released from the cells. Functional NPY-Venus and NPY-mRFP 
fusion proteins in neurons were demonstrated by Yizhar and Ashery.128  
We have shown that NPY-mRFP can also be used to label granules in non-neuronal 
RBL cells for exocytosis measurements.129 It may seem curious that NPY can be localized 
in granules of a non-neuronal cell line such as RBL-2H3, in particular considering the high 
quantity of proteases present in the granules. In 1983, Greenberg and Burnstock discovered 
that, in addition to phagocytosis of MCs granules by phagocytes, rat MCs could exchange 
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granules between other cell types via another mechanism, which they termed 
“transgranulation”, although in their study, transgranulation was only observed between 
MCs and fibroblasts or vascular endothelial cells. 130 Transgranulation between MCs and 
neurons was first described by Wilhelm et al. in 2005, who investigated mast cell-rich brain 
tissue from doves.131 The transgranulation mechanism may be a possible means of 
communication between MCs and neurons, and may give a clue as to how MC granules, or 
in this case, RBL granules, may be similar enough to neuron granules to display similar 
cellular NPY localization. In addition, neurons may also secrete NPY in response to 
increases in cytosolic Ca2+,126 similar to MC and basophil degranulation in response to Ca2+ 
influx, which demonstrates more similarities between MC, basophil and neuron behavior. 
Similarly to the NFAT luciferase or fluorescent protein reporters, we hypothesized that 
RBL cells stably transfected with NPY-mRFP and HsFcεRIα could result in a convenient 
way to detect allergic sensitization in human patient sera. Stable transfectants could be 
sensitized with the sera and exposed to allergen. Presence of clinically relevant allergen-
specific IgE would cause degranulation in response to allergen stimulation, and release of 
NPY-mRFP, measurable by quantifying fluorescence in the supernatant (or, if needed, the 
decrease of red fluorescence in the cells after removing the supernatant and a few washes) 
(Figure 1). The advantages over the NFAT-luciferase and NFAT-DsRed RBL reporters 
consists in the lack of a need for expensive luciferase substrates and a shorter assay time 
(0.75-1 hour vs. 18-24 hours), respectively (Figure 1). Although this assay is a soluble 
mediator assay, and unlike the aforementioned NFAT-DsRed cells, it would not be suitable 
for use in allergen microarrays. However, this assay would be faster than the traditionally 
used β-hexosaminidase assay, as there would be no requirement for a substrate-developing 
step, and would be a direct reporter of degranulation, unlike the cytokine induction 
reporters.  
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<Insert Figure 1 here> 
 
Finally, it is suggested here that when using RBL reporter cell lines for screening of anti-
allergic compounds, there may be some clear benefit of using a combination of NFAT 
reporters (e.g. luciferase or fluorescent protein) with degranulation reporters (e.g. NPY-
mRFP RBL) during screening. Assuming lack of toxicity, hits obtained with a candidate 
molecule in both cell lines, would point to inhibition of early events in IgE-dependent 
signal transduction, such as inhibition of syk or lyn kinases. In contrast, inhibition of one 
reporter, but not the other, would point to an inhibition of later steps in the signal 
transduction cascade (e.g. to events involved in membrane fusion or cytokine gene 
induction).  
 
5.2.4 RBL cells transiently transfected with NPY-mRFP as model for functional genomics 
analyses of MC secretion 
In the current post-genomic era functional genomics analyses are extensively applied to 
decipher signaling networks and protein interaction maps of cellular processes. In particular, 
high-throughput analyses employing RNAi or gain of function screens have opened new 
avenues for the systematic analyses of pathways. Systematic knock-down of proteins allows the 
identification of essential proteins versus those that can be deleted without hampering the 
integrity of the network, thus contributing to the robustness of the system. Computational 
biology then allows recapitulation of data into predictive models, which can form the basis for 
future experiments and analyses. Moreover, by subsequent rescue experiments the network 
hierarchy can be defined and crucial points for networks cross-talk identified. In MCs, 
functional genomics analyses have been limited due to their low (10-30%) transfection 
efficiency. For example, genetic manipulations are unlikely to leave an impact on readouts of 
average secretion measured by conventional methodologies if only a small fraction of the 
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releasing cells is transfected. Therefore, the major approaches to investigate MC activation 
involved studies on MCs derived from gene specific knock-out mice,132 or stably transfected 
MCs. However, these approaches do not allow high-throughput analyses of cellular processes. 
To overcome this problem, we have recently introduced a model system that is based on the 
transient co-transfection of RBL cells with a gene of interest (i.e. WT, mutant or targeting 
shRNA) and NPY-mRFP, as a reporter for exocytosis.5, 129, 133 We have shown that NPY-mRFP 
is targeted to the SGs where it colocalizes with serotonin, the endogenous mediator, and is 
released alongside the endogenous mediators serotonin and -hexosaminidase.129 Because the 
fluorescence of mRFP is on the whole pH insensitive, the reporter allows visualization of the 
acidic SGs in both fixed and living cells. Optimizing the transfection conditions to yield 100% 
co-transfection of the two genes, the reporter and the gene of interest thus allows to measure 
release exclusively from the transfected, hence, genetically manipulated cells, irrespectively of 
the actual efficiency of transfection (see Figure 2).  
 
<Insert Figure 2 here> 
 
Since RBL cells can be grown in 96- or 384-well plates, and the release of NPY-mRFP can be 
measured by the use of a fluorescence plate reader, this model allows functional genomics 
analyses of MC secretion. For example, we have used this model to screen the family of Rab 
GTPases on their impact on exocytosis triggered by either the IgE receptor or the chemical 
combination of Ca2+ ionophore and the phorbol ester TPA.129 These studies could be further 
extended using the same model system to screen the kinome or any other gene family for their 
functional impact on secretion. Furthermore, a phenotypic screen can complement the 
functional screen, by taking advantage of the fact that the NPY-mRFP labeled SGs are easily 
 19 
detected, allowing characterization of their morphology, quantification of their size and number 
as well as their spatiotemporal positioning in resting and activated cells.5, 133 Indeed, taking 
advantage of these possibilities, we were able to define a role of the small GTPase Rab5 in SG 
fusion by observing an increase in SG size linked with the reduction of SGs numbers in RBL 
cells that were co-transfected to express NPY-mRFP and a constitutively active mutant of 
Rab5.79 Conversely, co-transfection of NPY-mRFP with shRNAs directed against Rab5A/B/C 
the Rab5 isoforms that are endogenously expressed in RBL cells resulted in an increased 
number of smaller SGs.79 This model also allowed us to demonstrate a role of Rab12 in 
regulating retrograde transport of the SGs. Specifically, we have shown that co-transfection of 
NPY-mRFP with a constitutively active mutant of Rab12, resulted in the perinuclear clustering 
of the SGs by a mechanism involving the motor protein dynein and its interacting protein RILP. 
Therefore, this model could be used in the future to screen for proteins that affect SG 
exocytosis as well as screen for proteins that impact SG morphology or transport. 
 
Concluding statements 
Overall, these examples show how RBL cells can and have been used for a multitude of 
purposes, ranging from powerful tools for the study of basic cellular mechanisms of 
intracellular membrane trafficking and exocytosis, to detection of allergens, vaccine safety 
studies and diagnosis of allergic sensitization. However, to which extent RBL cells can be used 
as model for studies on mechanisms underlying MC growth and survival or MC metabolics, 
needs to be determined experimentally in each individual case and would require verification 
before extrapolation of results.  
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Figure Legends 
Figure 1: Schematic representation of the three currently available RBL reporter cell lines 
RS-ATL8, NFAT-DsRed, and NPY-mRFP. In all three, RBL cells are sensitized overnight 
with serum or other IgE-containing solutions (sensitization step). The next day, cells can be 
challenged with a matching allergen, an anti-IgE antibody, or other stimuli leading to cell 
activation, such as Concanavalin A. Allergen will crosslink the IgE bound to the FcεRIα 
receptor chain and induce a kinase cascade involving the intracellular-tyrosine activating 
motifs (ITAM) on the FcεRIβ and/or γ-chains (not shown). This cascade will ultimately 
open Calcium release-activated channels (CRAC) in the membrane, leading to a sustained 
influx of Ca2+ ions into the cytosol. The elevation of intracellular Ca2+ activates calmodulin, 
which in turn activates the phosphatase calcineurin. Calcineurin will dephosphorylate 
cytosolic Nuclear Factor of Activated T-cells (NFAT), unmasking a nuclear localization 
signal (NLS). The NLS will lead to NFAT translocation from the cytosol into the nucleus, 
where it will bind to regulatory elements. In RS-ATL8 and NFAT-DsRed cells, NFAT 
nuclear translocation will result in transcription of luciferase and DsRed fluorescent protein, 
respectively. In NPY-mRFP, activation will result in the release of preformed, red 
fluorescence, which can be measured in the supernatant 45-60 minutes after activation, 
while luciferase and DsRed measurements require 3-4 hours or 18-24 hours of incubation, 
respectively. 
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Figure 2: Schematic representation of the use of RBL cells for functional genomics analyses of 
exocytosis. In this method, RBL cells are transiently co-transfected with the SG reporter NPY-
mRFP and a second gene of interest or corresponding control plasmid. Normally, cell 
electroporation in the presence of the reporter and the manipulating gene at a 1:1 ratio will 
result in their co-expression in the majority of cells. Occasionally, increasing the amount of the 
manipulating gene is required to ascertain that all NPY-mRFP expressing cells, do also co-
express the manipulating gene. Therefore, regardless to the percentage of transfected cells (i.e. 
efficiency of transfection), measuring the amount of NPY-mRFP in cell supernatants 
exclusively monitors release from the genetically manipulated cells, unlike measurements of 
endogenous mediators that are also released by non-transfected cells. Following their 
electroporation, cells are immediately seeded in 96/384-well plates and sensitized with IgE, if 
required. Twenty-four hours later, cells are activated by either the corresponding antigen 
(allergen), anti IgE or any other stimulus for the desired times. Supernatants containing 
released NPY-mRFP are then transferred to 96/384-well plates and fluorescence of released 
and residual cellular mRFP are measured using a fluorescence plate reader, allowing the 
quantification of release (i.e. percentage of NPY-mRFP released). 
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Figure 1 
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